02005 石四藥集團
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
19/03/2026四川科倫藥業股份有限公司1711(L)468,296,000(L)680,686,000(L)23.07
10/03/2026UBS Group AG1213(L)-13,317,171(L)165,156,131(L)5.60
05/03/2026UBS Group AG1313(L)7,980,000(L)184,640,893(L)6.26
27/02/2026UBS Group AG1313(L)6,104,000(L)185,008,997(L)6.27
25/02/2026UBS Group AG1313(L)3,224,900(L)184,940,486(L)6.27
05/02/2026UBS Group AG1502(S)-1,456,000(S)184,114,599(L)
28,228,032(S)		6.35
0.97
19/01/2026UBS Group AG1402(S)+394,800(S)185,359,396(L)
29,310,829(S)		6.39
1.01
14/01/2026UBS Group AG1502(S)-744,000(S)184,952,596(L)
28,556,029(S)		6.38
0.98
09/01/2026曲繼廣1113(L)+456,000(L)HKD 3.045(L)1,233,292,000(L)41.79
08/01/2026曲繼廣1113(L)+1,486,000(L)HKD 3.043(L)1,232,836,000(L)41.77
07/01/2026曲繼廣1113(L)+1,128,000(L)HKD 3.020(L)1,231,350,000(L)41.72
06/01/2026曲繼廣1113(L)+1,500,000(L)HKD 2.980(L)1,230,222,000(L)41.68
05/01/2026曲繼廣1113(L)+1,100,000(L)HKD 2.898(L)1,228,722,000(L)41.63
22/12/2025UBS Group AG1402(S)+170,000(S)185,116,122(L)
29,081,222(S)		6.37
1.00
01/12/2025曲繼廣1113(L)+1,000,000(L)HKD 3.101(L)1,227,622,000(L)41.60
01/12/2025China Pharmaceutical Company Limited1710(L)+1,000,000(L)HKD 3.101(L)890,204,000(L)30.17
28/11/2025曲繼廣1113(L)+600,000(L)HKD 3.058(L)1,226,622,000(L)41.56
28/11/2025China Pharmaceutical Company Limited1710(L)+600,000(L)HKD 3.058(L)889,204,000(L)30.13
26/11/2025曲繼廣1113(L)+2,300,000(L)HKD 3.060(L)1,226,022,000(L)41.54
26/11/2025China Pharmaceutical Company Limited1710(L)+2,300,000(L)HKD 3.060(L)888,604,000(L)30.11
25/11/2025曲繼廣1113(L)+2,000,000(L)HKD 2.983(L)1,223,722,000(L)41.46
24/11/2025UBS Group AG1313(L)900,000(L)184,658,154(L)6.35
31/10/2025四川科倫藥業股份有限公司1101(L)+1,128,000(L)HKD 3.098(L)679,558,000(L)23.03
31/10/2025UBS Group AG1502(S)-1,400,000(S)187,397,222(L)
28,528,669(S)		6.45
0.98
30/10/2025曲繼廣1113(L)+5,000,000(L)HKD 3.083(L)1,221,722,000(L)41.39
28/10/2025UBS Group AG1402(S)+882,468(S)188,491,222(L)
29,546,669(S)		6.47
1.01
27/10/2025UBS Group AG1502(S)-700,000(S)187,557,350(L)
28,582,797(S)		6.44
0.98
21/10/2025曲繼廣1113(L)+2,100,000(L)HKD 2.896(L)1,216,722,000(L)41.22
15/10/2025UBS Group AG1402(S)+1,400,000(S)189,409,222(L)
29,850,669(S)		6.50
1.02
14/10/2025曲繼廣1113(L)+2,100,000(L)HKD 2.900(L)1,214,622,000(L)41.15
10/10/2025曲繼廣1113(L)+1,500,000(L)HKD 2.953(L)1,212,522,000(L)41.08
09/10/2025曲繼廣1113(L)+1,230,000(L)HKD 2.960(L)1,211,022,000(L)41.03
09/10/2025China Pharmaceutical Company Limited1101(L)+1,230,000(L)HKD 2.960(L)886,304,000(L)30.03
08/10/2025曲繼廣1113(L)+2,000,000(L)HKD 2.863(L)1,209,792,000(L)40.99
06/10/2025曲繼廣1113(L)+3,000,000(L)HKD 2.900(L)1,207,792,000(L)40.92
26/09/2025UBS Group AG1314(L)3,863,000(L)188,256,135(L)6.44
25/09/2025China Pharmaceutical Company Limited1710(L)+1,200,000(L)HKD 2.966(L)885,074,000(L)29.99
25/09/2025曲繼廣1113(L)+1,200,000(L)HKD 2.966(L)1,204,792,000(L)40.82
24/09/2025China Pharmaceutical Company Limited1710(L)+1,000,000(L)HKD 2.912(L)883,874,000(L)29.95
24/09/2025曲繼廣1113(L)+1,000,000(L)HKD 2.912(L)1,203,592,000(L)40.78
 1    2    3    4  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.